실험실 자동화 시장 예측(2025-2030년)

The Laboratory Automation Market will rise from USD 5.406 billion in 2025 to USD 7.671 billion in 2030, with a 7.25% compound annual growth rate (CAGR).

Laboratory automation systems employ advanced instrumentation to streamline laboratory processes with minimal human intervention, enhancing efficiency, accuracy, and safety. These systems optimize tasks from single steps to entire workflows, reducing reagent use, minimizing waste, and increasing experimental throughput. The global laboratory automation market is poised for steady growth, driven by growing awareness of automation benefits, technological advancements, and rising investments in drug discovery and biotechnology. However, high production and deployment costs, along with slower adoption among small and medium-sized enterprises (SMEs), may impede market expansion.

Market Drivers

Hardware Segment Dominance

The hardware segment, encompassing laboratory robotics and automated workstations, holds the largest market share. The increasing need for accelerated research and pharmaceutical development fuels demand for these components, as they enhance productivity and streamline complex processes. Automated workstations, in particular, are adopted for their ability to handle high workloads efficiently, supporting scalability in laboratory operations and driving market growth.

Clinical Chemistry Applications

The clinical chemistry segment dominates due to its reliance on automation to manage high workloads with reduced manpower. The growing need for specialized laboratories with automated functions, such as result management, storage, and archiving, further boosts demand. Automation in clinical chemistry enhances precision and reduces lead times, aligning with the industry's push for operational efficiency and data reliability.

Market Restraints

High costs associated with developing and deploying automation systems pose a significant barrier, particularly for SMEs with limited budgets. Additionally, the slower adoption of advanced technologies in smaller labs, due to insufficient infrastructure or expertise, limits market penetration. These challenges necessitate cost-effective solutions and increased awareness to broaden adoption.

Market Segment Analysis

By offering, the market is divided into hardware and software, with hardware leading due to its critical role in automation systems. By application, clinical chemistry holds a dominant share, driven by high-throughput needs, followed by drug discovery and genomics. The biotechnology and pharmaceutical companies segment is the largest end-user, propelled by the need to manage product complexity, reduce operational costs, and accelerate drug development through automation. Other end-users include academic research and clinical diagnostics.

Geographically, North America commands the largest market share, supported by advanced healthcare infrastructure, widespread adoption of innovative technologies, and the presence of major players. The Asia-Pacific region is expected to experience the fastest growth, driven by increasing healthcare investments, rapid R&D sector development, and growing technology adoption in countries like China and India.

Competitive Landscape

Key players, such as F. Hoffmann-La Roche AG, are driving innovation through advanced solutions like AI, machine learning, and robotics. These companies pursue collaborative strategies, including product launches and partnerships, to expand their market presence across diverse applications. The focus is on delivering scalable, efficient automation systems that enhance productivity and data accuracy for end-users in biotechnology and pharmaceuticals.

Regional Analysis

North America's dominance stems from its robust healthcare ecosystem and early adoption of automation technologies. The Asia-Pacific region, however, is a hotspot for growth, fueled by rising healthcare infrastructure investments and expanding R&D activities. Emerging markets in South America also present opportunities, though adoption lags due to cost constraints.

The laboratory automation market is set for robust growth, driven by hardware advancements, clinical chemistry applications, and biotechnology/pharmaceutical demands. North America leads, while Asia-Pacific's rapid development signals strong potential. High costs and SME adoption barriers pose challenges, but ongoing innovations in AI and robotics, coupled with strategic investments, will sustain market momentum, enhancing efficiency and safety in laboratory processes.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The Laboratory Automation Market is analyzed into the following segments:

By Component

• Hardware
• Software
• Services

By Automation Type

• Modular
• Fully-Automated

By Application

• Immunodiagnostics
• Molecular Diagnostics
• Drug Development
• Hematology
• Others

By End-User

• Hospitals & Diagnostics Centers
• Pharmaceutical & Biotechnology Companies
• Research & Academic Institutes

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. LABORATORY AUTOMATION MARKET BY COMPONENT

• 5.1. Introduction
• 5.2. Hardware
• 5.3. Software
• 5.4. Services

6. LABORATORY AUTOMATION MARKET BY AUTOMATION TYPE

• 6.1. Introduction
• 6.2. Modular
• 6.3. Fully-Automated

7. LABORATORY AUTOMATION MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Immunodiagnostics
• 7.3. Molecular Diagnostics
• 7.4. Drug Development
• 7.5. Hematology
• 7.6. Others

8. LABORATORY AUTOMATION MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals & Diagnostics Centers
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Research & Academic Institutes

9. LABORATORY AUTOMATION MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Italy
  • 9.4.5. Spain
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Israel
  • 9.5.4. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Taiwan
  • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Danaher Corporation
• 11.2. Abbott Laboratories
• 11.3. PerkinElmer, Inc.
• 11.4. Tecan Trading AG
• 11.5. Synchron
• 11.6. Hudson Robotics Inc.
• 11.7. F. Hoffmann- La Roche AG
• 11.8. Scienion AG
• 11.9. Thermo Fisher Scientific
• 11.10. COPAN ITALIA spa
• 11.11. Horiba, Ltd.
• 11.12. Oracle Corporation
• 11.13. HighRes Biosolutions

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations